{"id":2211,"date":"2012-07-01T12:08:00","date_gmt":"2012-07-01T10:08:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2012\/leserbrief-thought-leadership"},"modified":"2012-07-01T12:08:00","modified_gmt":"2012-07-01T10:08:00","slug":"leserbrief-thought-leadership","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2012\/leserbrief-thought-leadership","title":{"rendered":"Leserbrief: \u201eThought Leadership\u201d"},"content":{"rendered":"<p>Dr. M. aus F. schreibt: >> Sie sprechen mit Ihrer Kritik an den sog. Advisory Boards (1) einen meines Erachtens sehr wichtigen Punkt an. Ich leite ein Herzkatheterlabor und werde in dieser Funktion sehr h\u00e4ufig von Vertretern der Industrie kontaktiert \u2013 offenbar, wie ich nun von Ihnen gelernt habe, als lokaler \u201eKey Opinion Leader\u201d (KOL). [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. M. aus F. schreibt: >> Sie sprechen mit Ihrer Kritik an den sog. Advisory Boards (1) einen meines Erachtens sehr wichtigen Punkt an. Ich leite ein Herzkatheterlabor und werde in dieser Funktion sehr h\u00e4ufig von Vertretern der Industrie kontaktiert \u2013 offenbar, wie ich nun von Ihnen gelernt habe, als lokaler \u201eKey Opinion Leader\u201d (KOL). [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[3548,4414,255,2680,3259,3260,1451,1452,3262,2229,257,843,846,1409,4411,1561],"class_list":["post-2211","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-abhaengigkeit","tag-advisory-board","tag-arzneimittel","tag-aerzte","tag-aerztekongresse","tag-aerztliche-fortbildung","tag-bias","tag-interessenkonflikte","tag-key-opinion-leaders","tag-marketing","tag-medikamente","tag-pharmaindustrie","tag-pharmazeutische-unternehmer","tag-studien","tag-thought-leadership","tag-werbung"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2211"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2211\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2211"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}